Sanofi and Cipla enters into distribution partnership to expand reach of CNS portfolio in India
Cipla will be responsible for the distribution of Sanofi India's six CNS brands including Frisium
Cipla will be responsible for the distribution of Sanofi India's six CNS brands including Frisium
Revenue from Operations stood at Rs. 2,607 crore, 25% YoY growth. Domestic revenue at Rs. 2,400 crore, 20% YoY growth and export revenue at Rs. 207 crore, 118% YoY growth
The Aptivate Champion Run witnessed an enthusiastic participation of over 4,000 Mumbaikars
Lupin Life encourages children from Mumbai, Thane, and Navi Mumbai to participate in Aptivate Champion Run
Softovac Liquifibre expands the Softovac product portfolio and provides a choice for consumers who prefer time-tested Ayurvedic ingredients
The launch of R3SET Detox Candies positions the brand at the forefront of the wellness journey
This product will be launched through Granules Consumer Health (GCH) division
This decision will accelerate growth for both its pharma & consumer healthcare businesses in India
The appointment is effective from May 01, 2023 for five years
Subscribe To Our Newsletter & Stay Updated